nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC22A8—Mercaptopurine—hematologic cancer	0.0392	0.643	CbGbCtD
Valaciclovir—SLC22A8—Methotrexate—hematologic cancer	0.0128	0.21	CbGbCtD
Valaciclovir—SLC22A6—Methotrexate—hematologic cancer	0.00892	0.146	CbGbCtD
Valaciclovir—SLC10A2—hematopoietic system—hematologic cancer	0.00775	0.282	CbGeAlD
Valaciclovir—SLC6A14—lung—hematologic cancer	0.00692	0.252	CbGeAlD
Valaciclovir—SLC10A2—blood—hematologic cancer	0.00514	0.187	CbGeAlD
Valaciclovir—Ganciclovir—SLC22A1—hematologic cancer	0.00396	0.562	CrCbGaD
Valaciclovir—Aciclovir—SLC22A1—hematologic cancer	0.00308	0.437	CrCbGaD
Valaciclovir—SLC22A8—hematopoietic system—hematologic cancer	0.00216	0.0786	CbGeAlD
Valaciclovir—SLC22A8—blood—hematologic cancer	0.00143	0.0521	CbGeAlD
Valaciclovir—SLC15A2—blood—hematologic cancer	0.00124	0.0452	CbGeAlD
Valaciclovir—SLC15A2—lung—hematologic cancer	0.00109	0.0397	CbGeAlD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	0.00104	0.00619	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—CYCS—hematologic cancer	0.00104	0.00616	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.00103	0.00614	CbGpPWpGaD
Valaciclovir—SLC15A2—testis—hematologic cancer	0.00103	0.0374	CbGeAlD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hematologic cancer	0.00102	0.00603	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.000963	0.00571	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000915	0.00543	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000851	0.00505	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000837	0.00497	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000778	0.00462	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—NQO1—hematologic cancer	0.000765	0.00454	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	0.00075	0.00445	CbGpPWpGaD
Valaciclovir—SLC15A2—lymph node—hematologic cancer	0.000746	0.0271	CbGeAlD
Valaciclovir—SLC6A14—NRF2 pathway—HSP90AA1—hematologic cancer	0.000719	0.00427	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000694	0.00412	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000684	0.00406	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000678	0.00403	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000646	0.00383	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000645	0.00383	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTP1—hematologic cancer	0.000638	0.00379	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000635	0.00377	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000622	0.00369	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000606	0.0036	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00059	0.0035	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000588	0.00349	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTM1—hematologic cancer	0.000586	0.00348	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—HGF—hematologic cancer	0.000586	0.00348	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—CREBBP—hematologic cancer	0.000579	0.00344	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000575	0.00341	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	0.000574	0.00341	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000555	0.00329	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000553	0.00328	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000549	0.00326	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000526	0.00312	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000526	0.00312	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000526	0.00312	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000526	0.00312	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.00051	0.00302	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—PDGFB—hematologic cancer	0.000504	0.00299	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000491	0.00291	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000489	0.0029	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000483	0.00287	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000481	0.00285	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000481	0.00285	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000481	0.00285	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000473	0.00281	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PHYH—hematologic cancer	0.000469	0.00278	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GMPS—hematologic cancer	0.000469	0.00278	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FTCD—hematologic cancer	0.000469	0.00278	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000464	0.00275	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000454	0.0027	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000453	0.00269	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000442	0.00262	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000437	0.00259	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000433	0.00257	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SMPD3—hematologic cancer	0.000429	0.00255	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.000428	0.00254	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000416	0.00247	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000404	0.0024	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.0004	0.00237	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000396	0.00235	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.00039	0.00231	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.00038	0.00226	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00038	0.00226	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000378	0.00225	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—B3GAT1—hematologic cancer	0.000375	0.00222	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ASNS—hematologic cancer	0.000375	0.00222	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—DCK—hematologic cancer	0.000375	0.00222	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000368	0.00219	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000368	0.00218	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.000366	0.00217	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000359	0.00213	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HDC—hematologic cancer	0.000355	0.00211	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000348	0.00207	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000348	0.00206	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000346	0.00205	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000342	0.00203	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000339	0.00201	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000337	0.002	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000331	0.00197	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000328	0.00195	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000327	0.00194	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CDA—hematologic cancer	0.000325	0.00193	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000324	0.00192	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000319	0.00189	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000316	0.00188	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PC—hematologic cancer	0.000313	0.00186	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.00031	0.00184	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000305	0.00181	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000304	0.0018	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GBA—hematologic cancer	0.000302	0.00179	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC35B2—hematologic cancer	0.000302	0.00179	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000302	0.00179	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.0003	0.00178	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.0003	0.00178	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000294	0.00175	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000283	0.00168	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000279	0.00166	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000279	0.00165	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTAP—hematologic cancer	0.000276	0.00164	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000276	0.00164	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000273	0.00162	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000273	0.00162	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000267	0.00159	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000262	0.00156	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000259	0.00154	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000254	0.00151	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000253	0.0015	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000252	0.0015	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000249	0.00148	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000248	0.00147	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FHL2—hematologic cancer	0.000246	0.00146	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000243	0.00145	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000243	0.00144	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AGRN—hematologic cancer	0.000241	0.00143	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—TGFB1—hematologic cancer	0.000239	0.00142	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.000238	0.00141	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000232	0.00138	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000231	0.00137	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.00023	0.00137	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HMMR—hematologic cancer	0.000229	0.00136	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—IDH2—hematologic cancer	0.000229	0.00136	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000227	0.00135	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000227	0.00135	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000227	0.00135	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000223	0.00132	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000217	0.00129	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000216	0.00128	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ARNTL—hematologic cancer	0.000215	0.00128	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000211	0.00126	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000211	0.00125	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000211	0.00125	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000211	0.00125	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.00021	0.00125	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CA9—hematologic cancer	0.000209	0.00124	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ACP5—hematologic cancer	0.000209	0.00124	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000207	0.00123	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NCOR2—hematologic cancer	0.000207	0.00123	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000205	0.00122	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000205	0.00122	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000203	0.0012	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—IDH1—hematologic cancer	0.000197	0.00117	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCC3—hematologic cancer	0.000195	0.00116	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TXN—hematologic cancer	0.000195	0.00116	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTO1—hematologic cancer	0.000195	0.00116	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000193	0.00115	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000192	0.00114	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SPHK1—hematologic cancer	0.00019	0.00113	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.00019	0.00113	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000188	0.00111	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000188	0.00111	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000188	0.00111	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UGT1A1—hematologic cancer	0.000183	0.00109	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000181	0.00107	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.00018	0.00107	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CRABP1—hematologic cancer	0.000178	0.00106	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC22A1—hematologic cancer	0.000178	0.00106	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALOX5—hematologic cancer	0.000174	0.00103	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000171	0.00102	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000169	0.001	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NUP98—hematologic cancer	0.000168	0.000997	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000167	0.00099	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000164	0.000976	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ADCY7—hematologic cancer	0.000163	0.000968	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NCOA3—hematologic cancer	0.000163	0.000968	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NUP214—hematologic cancer	0.000162	0.000961	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.00016	0.000952	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCG2—hematologic cancer	0.000159	0.000942	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTR—hematologic cancer	0.000159	0.000942	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000157	0.00093	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000157	0.00093	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000157	0.00093	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ENO2—hematologic cancer	0.000156	0.000924	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000155	0.000921	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000153	0.000906	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTT1—hematologic cancer	0.000151	0.000896	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000151	0.000894	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.00015	0.000888	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000149	0.000882	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000148	0.000881	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SDC1—hematologic cancer	0.000148	0.000876	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000147	0.00087	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000144	0.000855	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000141	0.000839	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000141	0.000837	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.000141	0.000836	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.00014	0.00083	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000139	0.000826	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000139	0.000824	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000136	0.000807	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000136	0.000806	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.000133	0.00079	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000132	0.000785	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000131	0.000775	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000129	0.000767	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000128	0.00076	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NQO1—hematologic cancer	0.000125	0.000745	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CD44—hematologic cancer	0.000125	0.000745	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000124	0.000738	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000124	0.000735	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000123	0.000733	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.000123	0.000729	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000121	0.00072	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000121	0.000718	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000121	0.000718	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYCS—hematologic cancer	0.000119	0.000705	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HSP90AA1—hematologic cancer	0.000118	0.0007	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000113	0.000672	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.000113	0.000668	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.00011	0.000651	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000108	0.00064	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000107	0.000635	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.000106	0.00063	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTP1—hematologic cancer	0.000105	0.000621	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.000105	0.00062	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000104	0.000616	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000103	0.000612	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000102	0.000604	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.000101	0.000601	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000101	0.000599	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCB1—hematologic cancer	9.9e-05	0.000588	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM1—hematologic cancer	9.61e-05	0.000571	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NCOR1—hematologic cancer	9.61e-05	0.000571	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	9.29e-05	0.000552	CbGpPWpGaD
Valaciclovir—Urinary tract disorder—Doxorubicin—hematologic cancer	9.21e-05	0.000125	CcSEcCtD
Valaciclovir—Urticaria—Triamcinolone—hematologic cancer	9.21e-05	0.000125	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—hematologic cancer	9.19e-05	0.000125	CcSEcCtD
Valaciclovir—Asthenia—Etoposide—hematologic cancer	9.17e-05	0.000125	CcSEcCtD
Valaciclovir—Body temperature increased—Triamcinolone—hematologic cancer	9.16e-05	0.000124	CcSEcCtD
Valaciclovir—Anaphylactic shock—Prednisone—hematologic cancer	9.16e-05	0.000124	CcSEcCtD
Valaciclovir—Oedema—Prednisone—hematologic cancer	9.16e-05	0.000124	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	9.15e-05	0.000543	CbGpPWpGaD
Valaciclovir—Urethral disorder—Doxorubicin—hematologic cancer	9.15e-05	0.000124	CcSEcCtD
Valaciclovir—Decreased appetite—Dexamethasone—hematologic cancer	9.14e-05	0.000124	CcSEcCtD
Valaciclovir—Decreased appetite—Betamethasone—hematologic cancer	9.14e-05	0.000124	CcSEcCtD
Valaciclovir—Nausea—Irinotecan—hematologic cancer	9.13e-05	0.000124	CcSEcCtD
Valaciclovir—Nausea—Mitoxantrone—hematologic cancer	9.13e-05	0.000124	CcSEcCtD
Valaciclovir—Immune system disorder—Epirubicin—hematologic cancer	9.11e-05	0.000124	CcSEcCtD
Valaciclovir—Infection—Prednisone—hematologic cancer	9.1e-05	0.000124	CcSEcCtD
Valaciclovir—Mediastinal disorder—Epirubicin—hematologic cancer	9.09e-05	0.000123	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Betamethasone—hematologic cancer	9.08e-05	0.000123	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	9.08e-05	0.000123	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—hematologic cancer	9.07e-05	0.000123	CcSEcCtD
Valaciclovir—Fatigue—Betamethasone—hematologic cancer	9.07e-05	0.000123	CcSEcCtD
Valaciclovir—Fatigue—Dexamethasone—hematologic cancer	9.07e-05	0.000123	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	9.05e-05	0.000537	CbGpPWpGaD
Valaciclovir—Chills—Epirubicin—hematologic cancer	9.05e-05	0.000123	CcSEcCtD
Valaciclovir—Pruritus—Etoposide—hematologic cancer	9.04e-05	0.000123	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	9e-05	0.000534	CbGpPWpGaD
Valaciclovir—Pain—Betamethasone—hematologic cancer	8.99e-05	0.000122	CcSEcCtD
Valaciclovir—Pain—Dexamethasone—hematologic cancer	8.99e-05	0.000122	CcSEcCtD
Valaciclovir—Nervous system disorder—Prednisone—hematologic cancer	8.98e-05	0.000122	CcSEcCtD
Valaciclovir—Tachycardia—Prednisone—hematologic cancer	8.94e-05	0.000121	CcSEcCtD
Valaciclovir—Alopecia—Epirubicin—hematologic cancer	8.91e-05	0.000121	CcSEcCtD
Valaciclovir—Skin disorder—Prednisone—hematologic cancer	8.9e-05	0.000121	CcSEcCtD
Valaciclovir—Nausea—Gemcitabine—hematologic cancer	8.89e-05	0.000121	CcSEcCtD
Valaciclovir—Vomiting—Cisplatin—hematologic cancer	8.87e-05	0.00012	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—hematologic cancer	8.82e-05	0.00012	CcSEcCtD
Valaciclovir—Rash—Cisplatin—hematologic cancer	8.8e-05	0.000119	CcSEcCtD
Valaciclovir—Dermatitis—Cisplatin—hematologic cancer	8.79e-05	0.000119	CcSEcCtD
Valaciclovir—Diarrhoea—Etoposide—hematologic cancer	8.74e-05	0.000119	CcSEcCtD
Valaciclovir—Anorexia—Prednisone—hematologic cancer	8.73e-05	0.000119	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—hematologic cancer	8.67e-05	0.000118	CcSEcCtD
Valaciclovir—Feeling abnormal—Dexamethasone—hematologic cancer	8.67e-05	0.000118	CcSEcCtD
Valaciclovir—Feeling abnormal—Betamethasone—hematologic cancer	8.67e-05	0.000118	CcSEcCtD
Valaciclovir—Flatulence—Epirubicin—hematologic cancer	8.65e-05	0.000118	CcSEcCtD
Valaciclovir—Tension—Epirubicin—hematologic cancer	8.61e-05	0.000117	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Betamethasone—hematologic cancer	8.6e-05	0.000117	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.6e-05	0.000117	CcSEcCtD
Valaciclovir—Hypersensitivity—Triamcinolone—hematologic cancer	8.54e-05	0.000116	CcSEcCtD
Valaciclovir—Nervousness—Epirubicin—hematologic cancer	8.53e-05	0.000116	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—MTHFR—hematologic cancer	8.5e-05	0.000504	CbGpPWpGaD
Valaciclovir—Back pain—Epirubicin—hematologic cancer	8.49e-05	0.000115	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	8.49e-05	0.000504	CbGpPWpGaD
Valaciclovir—Dizziness—Etoposide—hematologic cancer	8.45e-05	0.000115	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—hematologic cancer	8.43e-05	0.000114	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—hematologic cancer	8.41e-05	0.000114	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—hematologic cancer	8.4e-05	0.000114	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—hematologic cancer	8.37e-05	0.000114	CcSEcCtD
Valaciclovir—Urticaria—Dexamethasone—hematologic cancer	8.36e-05	0.000114	CcSEcCtD
Valaciclovir—Urticaria—Betamethasone—hematologic cancer	8.36e-05	0.000114	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.35e-05	0.000113	CcSEcCtD
Valaciclovir—Dizziness—Prednisolone—hematologic cancer	8.34e-05	0.000113	CcSEcCtD
Valaciclovir—Asthenia—Triamcinolone—hematologic cancer	8.32e-05	0.000113	CcSEcCtD
Valaciclovir—Body temperature increased—Dexamethasone—hematologic cancer	8.31e-05	0.000113	CcSEcCtD
Valaciclovir—Body temperature increased—Betamethasone—hematologic cancer	8.31e-05	0.000113	CcSEcCtD
Valaciclovir—Abdominal pain—Betamethasone—hematologic cancer	8.31e-05	0.000113	CcSEcCtD
Valaciclovir—Abdominal pain—Dexamethasone—hematologic cancer	8.31e-05	0.000113	CcSEcCtD
Valaciclovir—Nausea—Cisplatin—hematologic cancer	8.29e-05	0.000113	CcSEcCtD
Valaciclovir—Insomnia—Prednisone—hematologic cancer	8.28e-05	0.000113	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—hematologic cancer	8.24e-05	0.000112	CcSEcCtD
Valaciclovir—Paraesthesia—Prednisone—hematologic cancer	8.23e-05	0.000112	CcSEcCtD
Valaciclovir—Pruritus—Triamcinolone—hematologic cancer	8.2e-05	0.000111	CcSEcCtD
Valaciclovir—Cough—Methotrexate—hematologic cancer	8.18e-05	0.000111	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—hematologic cancer	8.13e-05	0.00011	CcSEcCtD
Valaciclovir—Vomiting—Etoposide—hematologic cancer	8.13e-05	0.00011	CcSEcCtD
Valaciclovir—Anaemia—Epirubicin—hematologic cancer	8.11e-05	0.00011	CcSEcCtD
Valaciclovir—Agitation—Epirubicin—hematologic cancer	8.07e-05	0.00011	CcSEcCtD
Valaciclovir—Dyspepsia—Prednisone—hematologic cancer	8.06e-05	0.00011	CcSEcCtD
Valaciclovir—Rash—Etoposide—hematologic cancer	8.06e-05	0.000109	CcSEcCtD
Valaciclovir—Dermatitis—Etoposide—hematologic cancer	8.05e-05	0.000109	CcSEcCtD
Valaciclovir—Headache—Etoposide—hematologic cancer	8.01e-05	0.000109	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—hematologic cancer	8e-05	0.000109	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—hematologic cancer	7.99e-05	0.000108	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—hematologic cancer	7.99e-05	0.000108	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—hematologic cancer	7.99e-05	0.000108	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—hematologic cancer	7.97e-05	0.000108	CcSEcCtD
Valaciclovir—Decreased appetite—Prednisone—hematologic cancer	7.96e-05	0.000108	CcSEcCtD
Valaciclovir—Rash—Prednisolone—hematologic cancer	7.95e-05	0.000108	CcSEcCtD
Valaciclovir—Dermatitis—Prednisolone—hematologic cancer	7.94e-05	0.000108	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.93e-05	0.000108	CcSEcCtD
Valaciclovir—Fatigue—Prednisone—hematologic cancer	7.9e-05	0.000107	CcSEcCtD
Valaciclovir—Headache—Prednisolone—hematologic cancer	7.9e-05	0.000107	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—hematologic cancer	7.89e-05	0.000107	CcSEcCtD
Valaciclovir—Leukopenia—Epirubicin—hematologic cancer	7.86e-05	0.000107	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—hematologic cancer	7.86e-05	0.000107	CcSEcCtD
Valaciclovir—Constipation—Prednisone—hematologic cancer	7.83e-05	0.000106	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	7.76e-05	0.00046	CbGpPWpGaD
Valaciclovir—Confusional state—Methotrexate—hematologic cancer	7.72e-05	0.000105	CcSEcCtD
Valaciclovir—Dizziness—Triamcinolone—hematologic cancer	7.67e-05	0.000104	CcSEcCtD
Valaciclovir—Cough—Epirubicin—hematologic cancer	7.66e-05	0.000104	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—hematologic cancer	7.66e-05	0.000104	CcSEcCtD
Valaciclovir—Convulsion—Epirubicin—hematologic cancer	7.61e-05	0.000103	CcSEcCtD
Valaciclovir—Infection—Methotrexate—hematologic cancer	7.61e-05	0.000103	CcSEcCtD
Valaciclovir—Nausea—Etoposide—hematologic cancer	7.59e-05	0.000103	CcSEcCtD
Valaciclovir—Hypertension—Epirubicin—hematologic cancer	7.58e-05	0.000103	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.55e-05	0.000448	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	7.55e-05	0.000448	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Prednisone—hematologic cancer	7.55e-05	0.000103	CcSEcCtD
Valaciclovir—Asthenia—Betamethasone—hematologic cancer	7.55e-05	0.000103	CcSEcCtD
Valaciclovir—Asthenia—Dexamethasone—hematologic cancer	7.55e-05	0.000103	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—hematologic cancer	7.51e-05	0.000102	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—hematologic cancer	7.51e-05	0.000102	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—hematologic cancer	7.5e-05	0.000102	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Prednisone—hematologic cancer	7.49e-05	0.000102	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.49e-05	0.000444	CbGpPWpGaD
Valaciclovir—Nausea—Prednisolone—hematologic cancer	7.49e-05	0.000102	CcSEcCtD
Valaciclovir—Chest pain—Epirubicin—hematologic cancer	7.47e-05	0.000102	CcSEcCtD
Valaciclovir—Myalgia—Epirubicin—hematologic cancer	7.47e-05	0.000102	CcSEcCtD
Valaciclovir—Arthralgia—Epirubicin—hematologic cancer	7.47e-05	0.000102	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—hematologic cancer	7.46e-05	0.000101	CcSEcCtD
Valaciclovir—Pruritus—Betamethasone—hematologic cancer	7.44e-05	0.000101	CcSEcCtD
Valaciclovir—Pruritus—Dexamethasone—hematologic cancer	7.44e-05	0.000101	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—hematologic cancer	7.44e-05	0.000101	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	7.42e-05	0.000101	CcSEcCtD
Valaciclovir—Vomiting—Triamcinolone—hematologic cancer	7.37e-05	0.0001	CcSEcCtD
Valaciclovir—Rash—Triamcinolone—hematologic cancer	7.31e-05	9.93e-05	CcSEcCtD
Valaciclovir—Dry mouth—Epirubicin—hematologic cancer	7.31e-05	9.93e-05	CcSEcCtD
Valaciclovir—Dermatitis—Triamcinolone—hematologic cancer	7.3e-05	9.92e-05	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—hematologic cancer	7.3e-05	9.91e-05	CcSEcCtD
Valaciclovir—Urticaria—Prednisone—hematologic cancer	7.28e-05	9.89e-05	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—hematologic cancer	7.27e-05	9.88e-05	CcSEcCtD
Valaciclovir—Headache—Triamcinolone—hematologic cancer	7.26e-05	9.87e-05	CcSEcCtD
Valaciclovir—Abdominal pain—Prednisone—hematologic cancer	7.24e-05	9.84e-05	CcSEcCtD
Valaciclovir—Body temperature increased—Prednisone—hematologic cancer	7.24e-05	9.84e-05	CcSEcCtD
Valaciclovir—Confusional state—Epirubicin—hematologic cancer	7.22e-05	9.81e-05	CcSEcCtD
Valaciclovir—Diarrhoea—Betamethasone—hematologic cancer	7.2e-05	9.78e-05	CcSEcCtD
Valaciclovir—Diarrhoea—Dexamethasone—hematologic cancer	7.2e-05	9.78e-05	CcSEcCtD
Valaciclovir—Anaphylactic shock—Epirubicin—hematologic cancer	7.16e-05	9.73e-05	CcSEcCtD
Valaciclovir—Oedema—Epirubicin—hematologic cancer	7.16e-05	9.73e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—hematologic cancer	7.14e-05	0.000424	CbGpPWpGaD
Valaciclovir—Infection—Epirubicin—hematologic cancer	7.12e-05	9.67e-05	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—hematologic cancer	7.09e-05	9.63e-05	CcSEcCtD
Valaciclovir—Convulsion—Doxorubicin—hematologic cancer	7.04e-05	9.56e-05	CcSEcCtD
Valaciclovir—Nervous system disorder—Epirubicin—hematologic cancer	7.03e-05	9.54e-05	CcSEcCtD
Valaciclovir—Thrombocytopenia—Epirubicin—hematologic cancer	7.01e-05	9.53e-05	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—hematologic cancer	7.01e-05	9.53e-05	CcSEcCtD
Valaciclovir—Tachycardia—Epirubicin—hematologic cancer	6.99e-05	9.5e-05	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	6.97e-05	9.48e-05	CcSEcCtD
Valaciclovir—Skin disorder—Epirubicin—hematologic cancer	6.96e-05	9.45e-05	CcSEcCtD
Valaciclovir—Dizziness—Dexamethasone—hematologic cancer	6.96e-05	9.45e-05	CcSEcCtD
Valaciclovir—Dizziness—Betamethasone—hematologic cancer	6.96e-05	9.45e-05	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—hematologic cancer	6.92e-05	9.41e-05	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—hematologic cancer	6.91e-05	9.39e-05	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—hematologic cancer	6.91e-05	9.39e-05	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—hematologic cancer	6.91e-05	9.39e-05	CcSEcCtD
Valaciclovir—Nausea—Triamcinolone—hematologic cancer	6.89e-05	9.35e-05	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—hematologic cancer	6.87e-05	9.34e-05	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.87e-05	9.33e-05	CcSEcCtD
Valaciclovir—Anorexia—Epirubicin—hematologic cancer	6.83e-05	9.28e-05	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—hematologic cancer	6.82e-05	9.27e-05	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—hematologic cancer	6.81e-05	9.25e-05	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—hematologic cancer	6.76e-05	9.19e-05	CcSEcCtD
Valaciclovir—Hypersensitivity—Prednisone—hematologic cancer	6.75e-05	9.17e-05	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—hematologic cancer	6.74e-05	9.15e-05	CcSEcCtD
Valaciclovir—Vomiting—Dexamethasone—hematologic cancer	6.69e-05	9.09e-05	CcSEcCtD
Valaciclovir—Vomiting—Betamethasone—hematologic cancer	6.69e-05	9.09e-05	CcSEcCtD
Valaciclovir—Confusional state—Doxorubicin—hematologic cancer	6.68e-05	9.08e-05	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—hematologic cancer	6.65e-05	9.04e-05	CcSEcCtD
Valaciclovir—Rash—Betamethasone—hematologic cancer	6.63e-05	9.01e-05	CcSEcCtD
Valaciclovir—Rash—Dexamethasone—hematologic cancer	6.63e-05	9.01e-05	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—hematologic cancer	6.63e-05	9.01e-05	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—hematologic cancer	6.63e-05	9.01e-05	CcSEcCtD
Valaciclovir—Dermatitis—Dexamethasone—hematologic cancer	6.63e-05	9e-05	CcSEcCtD
Valaciclovir—Dermatitis—Betamethasone—hematologic cancer	6.63e-05	9e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CREBBP—hematologic cancer	6.62e-05	0.000393	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.61e-05	8.98e-05	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—hematologic cancer	6.6e-05	8.97e-05	CcSEcCtD
Valaciclovir—Headache—Betamethasone—hematologic cancer	6.59e-05	8.95e-05	CcSEcCtD
Valaciclovir—Headache—Dexamethasone—hematologic cancer	6.59e-05	8.95e-05	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—hematologic cancer	6.59e-05	8.95e-05	CcSEcCtD
Valaciclovir—Asthenia—Prednisone—hematologic cancer	6.57e-05	8.93e-05	CcSEcCtD
Valaciclovir—Pain—Methotrexate—hematologic cancer	6.55e-05	8.89e-05	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.53e-05	8.87e-05	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—hematologic cancer	6.5e-05	8.83e-05	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—hematologic cancer	6.49e-05	8.82e-05	CcSEcCtD
Valaciclovir—Pruritus—Prednisone—hematologic cancer	6.48e-05	8.8e-05	CcSEcCtD
Valaciclovir—Insomnia—Epirubicin—hematologic cancer	6.48e-05	8.8e-05	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—hematologic cancer	6.47e-05	8.79e-05	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—hematologic cancer	6.44e-05	8.75e-05	CcSEcCtD
Valaciclovir—Paraesthesia—Epirubicin—hematologic cancer	6.43e-05	8.74e-05	CcSEcCtD
Valaciclovir—Dyspnoea—Epirubicin—hematologic cancer	6.39e-05	8.68e-05	CcSEcCtD
Valaciclovir—Somnolence—Epirubicin—hematologic cancer	6.37e-05	8.65e-05	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—hematologic cancer	6.32e-05	8.58e-05	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—hematologic cancer	6.31e-05	8.57e-05	CcSEcCtD
Valaciclovir—Dyspepsia—Epirubicin—hematologic cancer	6.31e-05	8.57e-05	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.3e-05	0.000374	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CD—hematologic cancer	6.28e-05	0.000373	CbGpPWpGaD
Valaciclovir—Diarrhoea—Prednisone—hematologic cancer	6.27e-05	8.51e-05	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—hematologic cancer	6.26e-05	8.5e-05	CcSEcCtD
Valaciclovir—Nausea—Dexamethasone—hematologic cancer	6.25e-05	8.49e-05	CcSEcCtD
Valaciclovir—Nausea—Betamethasone—hematologic cancer	6.25e-05	8.49e-05	CcSEcCtD
Valaciclovir—Decreased appetite—Epirubicin—hematologic cancer	6.23e-05	8.46e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ALB—hematologic cancer	6.2e-05	0.000368	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.18e-05	8.4e-05	CcSEcCtD
Valaciclovir—Fatigue—Epirubicin—hematologic cancer	6.18e-05	8.39e-05	CcSEcCtD
Valaciclovir—Pain—Epirubicin—hematologic cancer	6.13e-05	8.32e-05	CcSEcCtD
Valaciclovir—Constipation—Epirubicin—hematologic cancer	6.13e-05	8.32e-05	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.11e-05	0.000363	CbGpPWpGaD
Valaciclovir—Urticaria—Methotrexate—hematologic cancer	6.08e-05	8.26e-05	CcSEcCtD
Valaciclovir—Dizziness—Prednisone—hematologic cancer	6.06e-05	8.23e-05	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—hematologic cancer	6.05e-05	8.22e-05	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—hematologic cancer	6.05e-05	8.22e-05	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.04e-05	8.2e-05	CcSEcCtD
Valaciclovir—Insomnia—Doxorubicin—hematologic cancer	6e-05	8.14e-05	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—hematologic cancer	5.95e-05	8.09e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PIK3R1—hematologic cancer	5.93e-05	0.000352	CbGpPWpGaD
Valaciclovir—Dyspnoea—Doxorubicin—hematologic cancer	5.91e-05	8.03e-05	CcSEcCtD
Valaciclovir—Feeling abnormal—Epirubicin—hematologic cancer	5.9e-05	8.02e-05	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—hematologic cancer	5.89e-05	8.01e-05	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Epirubicin—hematologic cancer	5.86e-05	7.96e-05	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—hematologic cancer	5.83e-05	7.93e-05	CcSEcCtD
Valaciclovir—Vomiting—Prednisone—hematologic cancer	5.82e-05	7.91e-05	CcSEcCtD
Valaciclovir—Rash—Prednisone—hematologic cancer	5.78e-05	7.85e-05	CcSEcCtD
Valaciclovir—Dermatitis—Prednisone—hematologic cancer	5.77e-05	7.84e-05	CcSEcCtD
Valaciclovir—Decreased appetite—Doxorubicin—hematologic cancer	5.76e-05	7.83e-05	CcSEcCtD
Valaciclovir—Headache—Prednisone—hematologic cancer	5.74e-05	7.8e-05	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.72e-05	7.77e-05	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	5.72e-05	0.00034	CbGpPWpGaD
Valaciclovir—Fatigue—Doxorubicin—hematologic cancer	5.71e-05	7.76e-05	CcSEcCtD
Valaciclovir—Urticaria—Epirubicin—hematologic cancer	5.69e-05	7.73e-05	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.67e-05	0.000337	CbGpPWpGaD
Valaciclovir—Constipation—Doxorubicin—hematologic cancer	5.67e-05	7.7e-05	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—hematologic cancer	5.67e-05	7.7e-05	CcSEcCtD
Valaciclovir—Abdominal pain—Epirubicin—hematologic cancer	5.66e-05	7.69e-05	CcSEcCtD
Valaciclovir—Body temperature increased—Epirubicin—hematologic cancer	5.66e-05	7.69e-05	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—hematologic cancer	5.64e-05	7.66e-05	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—hematologic cancer	5.49e-05	7.46e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PIK3CB—hematologic cancer	5.47e-05	0.000325	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Doxorubicin—hematologic cancer	5.46e-05	7.42e-05	CcSEcCtD
Valaciclovir—Nausea—Prednisone—hematologic cancer	5.44e-05	7.39e-05	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.42e-05	7.36e-05	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—hematologic cancer	5.42e-05	7.36e-05	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.31e-05	0.000315	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Epirubicin—hematologic cancer	5.28e-05	7.17e-05	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—hematologic cancer	5.27e-05	7.15e-05	CcSEcCtD
Valaciclovir—Body temperature increased—Doxorubicin—hematologic cancer	5.24e-05	7.12e-05	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—hematologic cancer	5.24e-05	7.12e-05	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—hematologic cancer	5.24e-05	7.12e-05	CcSEcCtD
Valaciclovir—Asthenia—Epirubicin—hematologic cancer	5.14e-05	6.98e-05	CcSEcCtD
Valaciclovir—Pruritus—Epirubicin—hematologic cancer	5.07e-05	6.89e-05	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—hematologic cancer	5.06e-05	6.88e-05	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.05e-05	0.0003	CbGpPWpGaD
Valaciclovir—Diarrhoea—Epirubicin—hematologic cancer	4.9e-05	6.66e-05	CcSEcCtD
Valaciclovir—Hypersensitivity—Doxorubicin—hematologic cancer	4.88e-05	6.63e-05	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—hematologic cancer	4.87e-05	6.61e-05	CcSEcCtD
Valaciclovir—Rash—Methotrexate—hematologic cancer	4.83e-05	6.56e-05	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—hematologic cancer	4.82e-05	6.55e-05	CcSEcCtD
Valaciclovir—Headache—Methotrexate—hematologic cancer	4.8e-05	6.52e-05	CcSEcCtD
Valaciclovir—Asthenia—Doxorubicin—hematologic cancer	4.76e-05	6.46e-05	CcSEcCtD
Valaciclovir—Dizziness—Epirubicin—hematologic cancer	4.74e-05	6.44e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PTEN—hematologic cancer	4.73e-05	0.000281	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	4.72e-05	0.00028	CbGpPWpGaD
Valaciclovir—Pruritus—Doxorubicin—hematologic cancer	4.69e-05	6.37e-05	CcSEcCtD
Valaciclovir—Vomiting—Epirubicin—hematologic cancer	4.55e-05	6.19e-05	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—hematologic cancer	4.55e-05	6.18e-05	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—hematologic cancer	4.54e-05	6.16e-05	CcSEcCtD
Valaciclovir—Rash—Epirubicin—hematologic cancer	4.52e-05	6.14e-05	CcSEcCtD
Valaciclovir—Dermatitis—Epirubicin—hematologic cancer	4.51e-05	6.13e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—EP300—hematologic cancer	4.51e-05	0.000268	CbGpPWpGaD
Valaciclovir—Headache—Epirubicin—hematologic cancer	4.49e-05	6.1e-05	CcSEcCtD
Valaciclovir—Dizziness—Doxorubicin—hematologic cancer	4.38e-05	5.96e-05	CcSEcCtD
Valaciclovir—Nausea—Epirubicin—hematologic cancer	4.26e-05	5.78e-05	CcSEcCtD
Valaciclovir—Vomiting—Doxorubicin—hematologic cancer	4.21e-05	5.73e-05	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.21e-05	0.00025	CbGpPWpGaD
Valaciclovir—Rash—Doxorubicin—hematologic cancer	4.18e-05	5.68e-05	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—hematologic cancer	4.18e-05	5.67e-05	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—hematologic cancer	4.15e-05	5.64e-05	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	3.94e-05	0.000234	CbGpPWpGaD
Valaciclovir—Nausea—Doxorubicin—hematologic cancer	3.94e-05	5.35e-05	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—hematologic cancer	3.33e-05	0.000198	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—hematologic cancer	2.72e-05	0.000162	CbGpPWpGaD
